The emerging role of lipoproteins in atherogenesis: Beyond LDL cholesterol

Stephen Nicholls, Pia Lundman

Research output: Contribution to journalReview article

31 Citations (Scopus)

Abstract

Low-density lipoprotein cholesterol has a well-established role in atherogenesis and the development of coronary heart disease. However, despite effective lowering of low-density lipoprotein cholesterol, many patients continue to have cardiovascular events. It has subsequently emerged that several additional dyslipidemic states promote atherogenesis. In particular, the atherogenic lipoprotein phenotype comprising an elevation of triglycerides and triglyceride-rich lipoproteins; decreased concentrations of high-density lipoprotein cholesterol; and increased small, dense low-density lipoprotein cholesterol, in addition to impaired postprandial lipemia, have been demonstrated to have profound effects on the arterial wall. As such, these factors have become important targets in the development of effective strategies to prevent atherosclerotic cardiovascular disease.

LanguageEnglish
Pages187-195
Number of pages9
JournalSeminars in Vascular Medicine
Volume4
Issue number2
DOIs
Publication statusPublished - May 2004
Externally publishedYes

Keywords

  • Atherosclerosis
  • Endothelial function
  • HDL
  • Inflammation
  • Triglycerides

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Nicholls, Stephen ; Lundman, Pia. / The emerging role of lipoproteins in atherogenesis : Beyond LDL cholesterol. In: Seminars in Vascular Medicine. 2004 ; Vol. 4, No. 2. pp. 187-195.
@article{f73e288a09b7489db43da067e45e8a66,
title = "The emerging role of lipoproteins in atherogenesis: Beyond LDL cholesterol",
abstract = "Low-density lipoprotein cholesterol has a well-established role in atherogenesis and the development of coronary heart disease. However, despite effective lowering of low-density lipoprotein cholesterol, many patients continue to have cardiovascular events. It has subsequently emerged that several additional dyslipidemic states promote atherogenesis. In particular, the atherogenic lipoprotein phenotype comprising an elevation of triglycerides and triglyceride-rich lipoproteins; decreased concentrations of high-density lipoprotein cholesterol; and increased small, dense low-density lipoprotein cholesterol, in addition to impaired postprandial lipemia, have been demonstrated to have profound effects on the arterial wall. As such, these factors have become important targets in the development of effective strategies to prevent atherosclerotic cardiovascular disease.",
keywords = "Atherosclerosis, Endothelial function, HDL, Inflammation, Triglycerides",
author = "Stephen Nicholls and Pia Lundman",
year = "2004",
month = "5",
doi = "10.1055/s-2004-835377",
language = "English",
volume = "4",
pages = "187--195",
journal = "Seminars in Vascular Medicine",
issn = "1528-9648",
publisher = "Thieme Medical Publishers",
number = "2",

}

The emerging role of lipoproteins in atherogenesis : Beyond LDL cholesterol. / Nicholls, Stephen; Lundman, Pia.

In: Seminars in Vascular Medicine, Vol. 4, No. 2, 05.2004, p. 187-195.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The emerging role of lipoproteins in atherogenesis

T2 - Seminars in Vascular Medicine

AU - Nicholls, Stephen

AU - Lundman, Pia

PY - 2004/5

Y1 - 2004/5

N2 - Low-density lipoprotein cholesterol has a well-established role in atherogenesis and the development of coronary heart disease. However, despite effective lowering of low-density lipoprotein cholesterol, many patients continue to have cardiovascular events. It has subsequently emerged that several additional dyslipidemic states promote atherogenesis. In particular, the atherogenic lipoprotein phenotype comprising an elevation of triglycerides and triglyceride-rich lipoproteins; decreased concentrations of high-density lipoprotein cholesterol; and increased small, dense low-density lipoprotein cholesterol, in addition to impaired postprandial lipemia, have been demonstrated to have profound effects on the arterial wall. As such, these factors have become important targets in the development of effective strategies to prevent atherosclerotic cardiovascular disease.

AB - Low-density lipoprotein cholesterol has a well-established role in atherogenesis and the development of coronary heart disease. However, despite effective lowering of low-density lipoprotein cholesterol, many patients continue to have cardiovascular events. It has subsequently emerged that several additional dyslipidemic states promote atherogenesis. In particular, the atherogenic lipoprotein phenotype comprising an elevation of triglycerides and triglyceride-rich lipoproteins; decreased concentrations of high-density lipoprotein cholesterol; and increased small, dense low-density lipoprotein cholesterol, in addition to impaired postprandial lipemia, have been demonstrated to have profound effects on the arterial wall. As such, these factors have become important targets in the development of effective strategies to prevent atherosclerotic cardiovascular disease.

KW - Atherosclerosis

KW - Endothelial function

KW - HDL

KW - Inflammation

KW - Triglycerides

UR - http://www.scopus.com/inward/record.url?scp=7244236496&partnerID=8YFLogxK

U2 - 10.1055/s-2004-835377

DO - 10.1055/s-2004-835377

M3 - Review article

VL - 4

SP - 187

EP - 195

JO - Seminars in Vascular Medicine

JF - Seminars in Vascular Medicine

SN - 1528-9648

IS - 2

ER -